Log In

Forgot Password?
Create New Account

Loading... please wait

2022 Annual Meeting | C82 - Child Neurology: Neuro-oncology

Monday 04/04/22
03:30 PM - 05:30 PM PDT Add To Calendar
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Seminar
Sonia Partap, MD, FAAN
Child Neurology and Developmental Neurology, Neuro-oncology
Participants should be able to understand the current treatment strategies of pediatric CNS tumors, become familiar with the acute neurologic sequelae related to tumor and or cancer therapies, and anticipate late neurologic effects in survivors of these cancers.
2.00 CME credits
Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice
Intermediate
Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student
Didactic, Audience Participation

Program Materials Program Evaluations

Event Timeline
03:30 PM - 04:00 PM PDT Speaker Pediatric CNS Tumors: Review and Treatment Updates
Sonia Partap, MD, FAAN
03:30 PM - 03:30 PM PDT Speaker walk in slides
Sonia Partap, MD, FAAN
04:00 PM - 04:45 PM PDT Speaker Neurotoxicity in Pediatric Cancer Immunotherapy
Juliane Gust, MD, PhD
04:45 PM - 05:30 PM PDT Speaker Neurologic Sequelae in Adult Survivors of Pediatric CNS Tumors
Nicole Ullrich, MD, PhD, MMSci, FAAN
Faculty Disclosures
Sonia Partap, MD, FAAN The institution of Dr. Partap has received research support from NIH.
Nicole Ullrich, MD, PhD, MMSci, FAAN Dr. Ullrich has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Astra Zeneca. The institution of Dr. Ullrich has received research support from Children's Tumor Foundation. Dr. Ullrich has received intellectual property interests from a discovery or technology relating to health care. Dr. Ullrich has received publishing royalties from a publication relating to health care.
Juliane Gust, MD, PhD The institution of Dr. Gust has received research support from NINDS.